ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography

NCT01594736 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: ORSIRO
DEVICE: XIENCE PRIME DES

Sponsor

Deutsches Herzzentrum Muenchen

Collaborators

[object Object]